Saving lives through long-acting injectable innovation
Professor Steve Rannard is Co-director of the Centre of Excellence for Long-acting Therapeutics. Steve leads a team of chemists in developing long-acting formulations for malaria prevention. For World Malaria Day, Steve and his group spent some time to explain how their innovative technology can revolutionise malaria prevention in low- and middle-income countries.
Posted on: 24 April 2022
Reducing the burden of TB in the world’s most in need communities with long-acting injectables
Ketho Angami is a member of the Global TB Community Advisory Board and Long-Acting Technologies Community Advisory Board. In 2016 he received the National Leadership AIDS Award in India, and also the Nagaland State Governor’s award in 2021. Ketho has been engaged in the field of community led advocacy for more than 15 years, working actively in the field of Tuberculosis, HIV and Viral Hepatitis by holding governments accountable for preventable deaths from infectious diseases. He has been engaged with the grassroots population and generating community demands for quality of service on a human rights-based approach.
Posted on: 24 March 2022
Investing in TB prevention strategies with Long-Acting injectables
Susan Swindells is Professor of Internal Medicine in the Section of Infectious Diseases at the University of Nebraska Medical Center, USA. She is a contributing investigator on TB clinical development for the LONGEVITY project. A native of England, Dr. Swindells earned her medical degree from University College London in 1977, with postgraduate training in England and at the University of Washington in Seattle. A clinician and active researcher, Dr. Swindells has many years’ experience in HIV-related translational and clinical research, with a special interest in tuberculosis co-infection.
Posted on: 24 March 2022
Blog
Saving lives through long-acting injectable innovation
Professor Steve Rannard is Co-director of the Centre of Excellence for Long-acting Therapeutics. Steve leads a team of chemists in developing long-acting formulations for malaria prevention. For World Malaria Day, Steve and his group spent some time to explain how their innovative technology can revolutionise malaria prevention in low- and middle-income countries.
Posted on: 24 April 2022